Search research articles
Contact Us
Filters
Showing results (321-330 of 446) with videos related to
Page
of 45
Sort By:
American Journal of Hematology
|
July 8, 2023
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma
Saurabh Zanwar, Matthew Ho, Yi Lin, et al.
Blood
|
April 12, 2012
Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis
Angela Dispenzieri, Francis Buadi, Kristina Laumann, et al.
American Journal of Hematology
|
June 2, 2011
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial
Shaji K Kumar, Martha Q Lacy, Suzanne R Hayman, et al.
American Journal of Hematology
|
April 4, 2017
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia
Surbhi Sidana, S Vincent Rajkumar, Angela Dispenzieri, et al.
American Journal of Hematology
|
April 17, 2018
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma
Patrick W Mellors, Moritz Binder, Francis K Buadi, et al.
Mayo Clinic Proceedings
|
October 3, 2008
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative
Morie A Gertz, Stephen M Ansell, David Dingli, et al.
Mayo Clinic Proceedings
|
February 3, 2009
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component
John A Lust, Martha Q Lacy, Steven R Zeldenrust, et al.
Blood Cancer Journal
|
December 12, 2023
Muscle and fat composition in patients with newly diagnosed multiple myeloma
Nadine H Abdallah, Hiroki Nagayama, Naoki Takahashi, et al.
Blood Advances
|
August 21, 2023
Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy
Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
American Journal of Hematology
|
September 30, 2017
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL)
Nidhi Tandon, Surbhi Sidana, Angela Dispenzieri, et al.
Page
of 45
Search research articles
Search
Showing results (321-330 of 446) with videos related to
Sort By:
Page
of 45
American Journal of Hematology
|
July 8, 2023
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma
Saurabh Zanwar, Matthew Ho, Yi Lin, et al.
Blood
|
April 12, 2012
Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis
Angela Dispenzieri, Francis Buadi, Kristina Laumann, et al.
American Journal of Hematology
|
June 2, 2011
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial
Shaji K Kumar, Martha Q Lacy, Suzanne R Hayman, et al.
American Journal of Hematology
|
April 4, 2017
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia
Surbhi Sidana, S Vincent Rajkumar, Angela Dispenzieri, et al.
American Journal of Hematology
|
April 17, 2018
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma
Patrick W Mellors, Moritz Binder, Francis K Buadi, et al.
Mayo Clinic Proceedings
|
October 3, 2008
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative
Morie A Gertz, Stephen M Ansell, David Dingli, et al.
Mayo Clinic Proceedings
|
February 3, 2009
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component
John A Lust, Martha Q Lacy, Steven R Zeldenrust, et al.
Blood Cancer Journal
|
December 12, 2023
Muscle and fat composition in patients with newly diagnosed multiple myeloma
Nadine H Abdallah, Hiroki Nagayama, Naoki Takahashi, et al.
Blood Advances
|
August 21, 2023
Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy
Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
American Journal of Hematology
|
September 30, 2017
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL)
Nidhi Tandon, Surbhi Sidana, Angela Dispenzieri, et al.
Page
of 45